PhD in Pharmacology, University of Iowa
Genomics, common human disease
Howard Jacob is committed to bringing whole genome sequencing into a clinical setting, both for rare disease and to explore the use of the genomic sequence for preventive and predictive care. The Jacob lab is focused on developing a functional screening program to identify disease-causing variants and test potential treatments. Before joining HudsonAlpha, Jacob led a team of researchers and clinicians at the Medical College of Wisconsin (MCW) who developed and implemented the nation’s first fully integrated clinical genomics program. Prior to joining HudsonAlpha, Jacob was the founding director of the Human and Molecular Genetics Program and the Warren P. Knowles Professor of Genetics at MCW.
Maureen Mack comes to HudsonAlpha from the Medical College of Wisconsin (MCW) where she was the Director of External Communications and responsible for designing, developing and executing MCW’s external communications strategy. Mack also was instrumental in the extensive national media coverage of the Nicholas Volker case. Volker was the first child to be saved by DNA sequencing under the scientific leadership of internationally-renowned genomics expert Howard Jacob, Ph.D. Mack brings more than 15 years of communications expertise to HudsonAlpha and her role furthers the Institute’s mission of creating a healthier, more sustainable world through genomics.
Melissa DeVore leads all aspects of human resources, including employee administration, employee relations, talent management and performance management. Her goal is to align the direction, services and innovations of the human resources department with the direction and strategies of the Institute. Melissa has over 20 years as a leader in human resources in the government contracting, banking and staffing industries.
Pete Yanul leads the finance and accounting team and is responsible for all aspects of financial operations, financial analysis, modeling, budgeting, forecasting and performance management, with the goal of setting the Institute on a path toward long-term sustainability and building its reputation for transparency and operational excellence. A native New Yorker, he has more than 25 years of diverse financial management experience, having spent the last 10 years in the biotech and medical device industries. Yanul previously served in financial leadership roles at Nektar Therapeutics and Open Biosystems/Thermo Fisher Scientific and considers his return to Huntsville, Ala., an exciting homecoming.